The mission of the Geneva Biotech Center is to select promising projects through a rigorous due diligence process, to build a de-risked development path according to pharmaceutical quality standards, to offer an optimal development and valorization to its financial partners, in order to provide solid foundations for innovative therapies in disease areas with a high medical need.
Our Specialty: our Business Model
The Geneva Biotech Center operates under a tripartite partnership:
- Academia and Biotech companies, the source of molecules
- The Geneva Biotech Center experts to select, develop and valorize the projects
- A network of biotech Investors, specific for each project.
Scope of Activities
The expertise of the team at The Geneva Biotech Center and its network of consultants covers the part of the drug discovery pipeline with the highest valorization potential, whose scope extends from late preclinical development to clinical proof of concept.
Following the evaluation of proposed molecules, the Geneva Biotech Center selects those which appear to have the highest potential to succeed their clinical development, coupled with a high valorization potential, and then proceeds through the various stages of development by setting clear validation steps.